CONCLUDING R EMARKS
7. Contreras, F -X., A . M . E rnst, P . H aberkant, P . B jörkholm, E . L indahl,
B. Gönen, C. Tischer, A. Elofsson, G. von Heijne, C. Thiele, et al.
2
012. Molecular recognition of a single sphingolipid species by a
In t his w ork, w e d efined s tructural e lements n ear t he a c
tive site of SMS enzymes that impart catalytic specificity.
Residues in the second and third exoplasmic loops proxi
mal to the conserved catalytic triad turned out to be key
determinants of head group selectivity. Swapping these resi
dues with SMSr allowed conversion of the Golgi-resident
SMS, S MS1, i nto a b ulk p roducer o f C PE a nd t he e stablish
ment o f a m ammalian c ell l ine t hat s ynthesizes C PE r ather
than SM as the dominant phosphosphingolipid. CPE nor
mally represents only a minor fraction of the mammalian
sphingolipid pool, with steady state levels 300 to 1,500fold
below those of SM (20). In contrast, CPE is the dominant
phosphosphingolipid in most insects, including Drosophila
protein’s transmembrane domain. Nature. 481: 5 25–529.
8. Miller, M. E., S. Adhikary, A. A. Kolokoltsov, and R. A. Davey.
2012. Ebolavirus requires acid sphingomyelinase activity and
plasma membrane sphingomyelin for infection. J. Virol. 86:
7
473–7483.
9. Yamaji-Hasegawa, A., F. Hullin-Matsuda, P. Greimel, and T.
Kobayashi. 2016. Poreforming toxins: properties, diversity, and
uses as tools to image sphingomyelin and ceramide phosphoetha
nolamine. Biochim. Biophys. Acta. 10.1016/j.bbamem.2015.10.012.
0. Adada, M., C. Luberto, and D. Canals. 2016. Inhibitors of the
sphingomyelin cycle: sphingomyelin synthases and sphingomyelin
ases. Chem. Phys. Lipids. 10.1016/j.chemphyslip.2015.07.008.
1 1. Maceyka, M ., a nd S . S piegel. 2 014. S phingolipid m etabolites i n i n
flammatory disease. Nature. 510: 58–67.
1 2. Huitema, K ., J . v an d en D ikkenberg, J . F . H . M . B rouwers, a nd J . C .
1
M. Holthuis. 2004. Identification of a family of animal sphingomy
elin synthases. EMBO J. 23: 33–44.
(
22, 43). Unlike SM, CPE does not interact favorably with
cholesterol despite of its hydrogenbonding properties
44). This may explain why insects are auxotroph for sterols
2
(
elin synthesis and cell growth in sphingomyelin synthasedefective
lymphoid cells. J. Biol. Chem. 279: 1 8688–18693.
and have a more relaxed structural requirement for sterols
in their membranes than mammals, which appear highly
adapted to the use of cholesterol (45, 46). Substitution of
SM for CPE may therefore have a profound impact on cho
lesterol h omeostasis i n m ammalian c ells. O ur c urrent w ork
provides an ideal basis to test this prediction.
1 4. Tafesse, F . G ., K . H uitema, M . H ermansson, S . v an d er P oel, J . v an
den D ikkenberg, A . U phoff, P . S omerharju, a nd J . C . M . H olthuis.
2007. Both sphingomyelin synthases SMS1 and SMS2 are required
for sphingomyelin homeostasis and growth in human HeLa cells. J.
Biol. Chem. 282: 17537–17547.
1 5. Mitsutake, S ., K . Z ama, H . Y okota, T . Y oshida, M . T anaka, M . M itsui,
M. I kawa, M . O kabe, Y . T anaka, T . Y amashita, e t a l. 2 011. D ynamic
modification of sphingomyelin in lipid microdomains controls de
velopment of obesity, fatty liver, and type 2 diabetes. J. Biol. Chem.
At present, the physiological relevance of CPE biosynthe
sis in mammals is unclear (20, 21). We previously showed
that a cute d isruption o f S MSr-catalyzed C PE p roduction i n
cultured cells causes a deregulation of ER ceramides and
induction of mitochondrial apoptosis (18, 23). Whether
CPE acts as a signaling lipid in SMSrmediated ceramide
homeostasis remains to be established. To address this
possibility, our current efforts focus on manipulating ER
resident CPE pools by targeting activesiteengineered
2
86: 28544–28555.
16. Liu, J., C. Huan, M. Chakraborty, H. Zhang, D. Lu, M-S. Kuo, G.
Cao, and X-C. Jiang. 2009. Macrophage sphingomyelin synthase 2
deficiency decreases atherosclerosis in mice. Circ. Res. 105: 2 95–303.
1 7. Li, Z ., H . Z hang, J . L iu, C -P. L iang, Y . L i, G . T eitelman, T . B eyer, H .
H. B ui, D . A . P eake, Y . Z hang, e t a l. 2 011. R educing p lasma m em
brane sphingomyelin increases insulin sensitivity. Mol. Cell. Biol. 31:
4
205–4218.
J. F. H. M. Brouwers, P. Somerharju, C. Rabouille, and J. C. M.
Holthuis. 2 009. S phingomyelin s ynthase-related p rotein S MSr c on
trols ceramide homeostasis in the ER. J. Cell Biol. 185: 1013–1027.
CPE
SMS1 to the ER. The establishment of SMS variants with
altered head group selectivity not only provides fresh in
sight into the reaction mechanism underlying SM and CPE
biosynthesis, but should also facilitate the development of
isoenzyme-specific i nhibitors.
1 9. Ternes, P., J. F. H. M. Brouwers, J. van den Dikkenberg, and J. C.
M. H olthuis. 2 009. S phingomyelin s ynthase S MS2 d isplays d ual a c
tivity as ceramide phosphoethanolamine synthase. J. Lipid Res. 50:
2270–2277.
2 0. Bickert, A ., C . G inkel, M . K ol, K . v om D orp, H . J astrow, J . D egen,
R. L . J acobs, D . E . V ance, E . W interhager, X -C. J iang, e t a l. 2 015.
Functional c haracterization o f e nzymes c atalyzing c eramide p hos
phoethanolamine biosynthesis in mice. J. Lipid Res. 56: 821–835.
The a uthors t hank T arja G rundström f or t echnical a ssistance.
2 1. Ding, T., I. Kabir, Y. Li, C. Lou, A. Yazdanyar, J. Xu, J. Dong, H.
Zhou, T . P ark, M . B outjdir, e t a l. 2 015. A ll m embers i n t he s phingo
myelin synthase gene family have ceramide phosphoethanolamine
synthase activity. J. Lipid Res. 56: 537–545.
REFERENCES
2 2. Vacaru, A. M., J. van den Dikkenberg, P. Ternes, and J. C. M.
1. Slotte, J. P. 2013. Biological functions of sphingomyelins. Prog.
Lipid Res. 52: 424–437.
Holthuis. 2013. Ceramide phosphoethanolamine biosynthesis in
Drosophila is mediated by a unique ethanolamine phosphotrans
ferase i n t he G olgi l umen. J . Biol. Chem. 288: 11520–11530.
2. Slotte, J . P ., a nd E . L . B ierman. 1 988. D epletion o f p lasma-membrane
sphingomyelin rapidly alters the distribution of cholesterol between
plasma membranes and intracellular cholesterol pools in cultured
fibroblasts. Biochem. J. 250: 653–658.
2 3. Tafesse, F. G., A. M. Vacaru, E. F. Bosma, M. Hermansson, A.
Jain, A. Hilderink, P. Somerharju, and J. C. M. Holthuis. 2014.
Sphingomyelin synthaserelated protein SMSr is a suppressor
of ceramideinduced mitochondrial apoptosis. J. Cell Sci. 127:
445–454.
2 4. Tafesse, F . G ., P . T ernes, a nd J . C . M . H olthuis. 2 006. T he m ultigenic
sphingomyelin synthase family. J. Biol. Chem. 281: 2 9421–29425.
2 5. Yeang, C., S. Varshney, R. Wang, Y. Zhang, D. Ye, and X-C. Jiang.
2008. The domain responsible for sphingomyelin synthase (SMS)
activity. Biochim. Biophys. Acta. 1781: 610–617.
3. Gupta, A . K ., a nd H . R udney. 1 991. P lasma m embrane s phingomy
elin a nd t he r egulation o f H MG-CoA r eductase a ctivity a nd c holes
terol biosynthesis in cell cultures. J. Lipid Res. 32: 125–136.
4. Sharpe, H . J ., T . J . S tevens, a nd S . M unro. 2 010. A c omprehensive
comparison of transmembrane domains reveals organellespecific
properties. Cell. 142: 1 58–169.
5. Quiroga, R., A. Trenchi, A. González Montoro, J. Valdez Taubas,
and H. J. F. Maccioni. 2013. Short transmembrane domains with
highvolume exoplasmic halves determine retention of type II mem
brane p roteins i n t he G olgi c omplex. J . Cell Sci. 126: 5 344–5349.
2 6. Orr-Weaver, T . L ., J . W . S zostak, a nd R . J . R othstein. 1 983. G enetic
applications of yeast transformation with linear and gapped plas
mids. Methods Enzymol. 101: 228–245.
6. Milescu, M ., F . B osmans, S . L ee, A . A . A labi, J . I . K im, a nd K . J . S wartz.
009. Interactions between lipids and voltage sensor paddles de
tected with tarantula toxins. Nat. Struct. Mol. Biol. 16: 1080–1085.
2 7. Bartlett, E . M ., a nd D . H . L ewis. 1 970. S pectrophotometric d etermi
nation of phosphate esters in the presence and absence of ortho
phosphate. Anal. Biochem. 36: 1 59–167.
2
1
284
Journal of Lipid Research Volume 57, 2016